Wen Shi Lee

Wen Shi Lee

Auto-generated profile, based on publicly available information

Wen Shi Lee

The Peter Doherty Institute for Infection and Immunity, University of Melbourne

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 September 2020 in Nature Microbiology
Verified
Journal Article
Closed access
PDF file
WLWen Shi Lee
Wen Shi Lee
Adam WheatleyAdam Wheatley
Adam Wheatley
SKStephen J. Kent
Stephen J. Kent
BDBrandon J DeKosky
Brandon J DeKosky

13 July 2020 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
JJJennifer Juno
Jennifer Juno
HTHyon-Xhi Tan
Hyon-Xhi Tan
WLWen Shi Lee
Wen Shi Lee
ARArnold Reynaldi
Arnold Reynaldi
HKHannah G. Kelly
Hannah G. Kelly
Adam WheatleyAdam Wheatley
Adam Wheatley

27 June 2022 in ACS Nano
Verified
Journal Article
Closed access
YJYi Ju
Yi Ju
WLWen Shi Lee
Wen Shi Lee
EPEmily H. Pilkington
Emily H. Pilkington
HKHannah G. Kelly
Hannah G. Kelly
SLShiyao Li
Shiyao Li
SKStephen J. Kent
Stephen J. Kent

19 February 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
Adam WheatleyAdam Wheatley
Adam Wheatley
JJJennifer Juno
Jennifer Juno
JWJing J. Wang
Jing J. Wang
KSKevin J. Selva
Kevin J. Selva
ARArnold Reynaldi
Arnold Reynaldi
SKStephen J. Kent
Stephen J. Kent
The durability of infection-induced SARS-CoV-2 immunity has major implications for reinfection and vaccine development. Here, we show a comprehensive profile of antibody, B cell and T cell dynamics over time in a cohort of patients who have recovered from mild-moderate COVID-19. Binding and neutralising antibody responses, together with individual serum clonotypes, decay over the first 4 months post-infection. A similar decline in Spike-specific CD4+ and circulating T follicular helper frequencies occurs. By contrast, S-specific IgG+ memory B cells consistently accumulate over time, eventually comprising a substantial fraction of circulating the memory B cell pool. Modelling of the concomitant immune kinetics predicts maintenance of serological neutralising activity above a titre of 1:40 in 50% of convalescent participants to 74 days, although there is probably additive protection from B cell and T cell immunity. This study indicates that SARS-CoV-2 immunity after infection might be transiently protective at a population level. Therefore, SARS-CoV-2 vaccines might require greater immunogenicity and durability than natural infection to drive long-term protection.

1 April 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
KSKevin J. Selva
Kevin J. Selva
Carolien Emma van de SandtCarolien Emma van de Sandt
Carolien Emma van de Sandt
MLMelissa M. Lemke
Melissa M. Lemke
CLChristina Y. Lee
Christina Y. Lee
SSSuzanne K. Shoffner
Suzanne K. Shoffner
ACAmy W. Chung
Amy W. Chung
The hallmarks of COVID-19 are higher pathogenicity and mortality in the elderly compared to children. Examining baseline SARS-CoV-2 cross-reactive immunological responses, induced by circulating human coronaviruses (hCoVs), is needed to understand such divergent clinical outcomes. Here we show analysis of coronavirus antibody responses of pre-pandemic healthy children (n = 89), adults (n = 98), elderly (n = 57), and COVID-19 patients (n = 50) by systems serology. Moderate levels of cross-reactive, but non-neutralizing, SARS-CoV-2 antibodies are detected in pre-pandemic healthy individuals. SARS-CoV-2 antigen-specific Fcγ receptor binding accurately distinguishes COVID-19 patients from healthy individuals, suggesting that SARS-CoV-2 infection induces qualitative changes to antibody Fc, enhancing Fcγ receptor engagement. Higher cross-reactive SARS-CoV-2 IgA and IgG are observed in healthy elderly, while healthy children display elevated SARS-CoV-2 IgM, suggesting that children have fewer hCoV exposures, resulting in less-experienced but more polyreactive humoral immunity. Age-dependent analysis of COVID-19 patients, confirms elevated class-switched antibodies in elderly, while children have stronger Fc responses which we demonstrate are functionally different. These insights will inform COVID-19 vaccination strategies, improved serological diagnostics and therapeutics.

26 November 2018 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
MPMatthew Parsons
Matthew Parsons
WLWen Shi Lee
Wen Shi Lee
AKAnne B. Kristensen
Anne B. Kristensen
TAThakshila Amarasena
Thakshila Amarasena
GKGeorges Khoury
Georges Khoury
SKStephen J. Kent
Stephen J. Kent
A considerable body of evidence suggests that Fc-dependent functions improve the capacity of broadly neutralizing antibodies (BnAbs) to protect against and control HIV-1 infection. This phenomenon, however, has not been formally tested in robust cell-associated macaque simian-human immunodeficiency virus (SHIV) models with newer-generation BnAbs. We studied both the WT BnAb PGT121 and a LALA mutant of PGT121 (which has impaired Fc-dependent functions) for their ability to protect pigtail macaques from an i.v. high-dose cell-associated SHIVSF162P3 challenge. We found that both WT and LALA PGT121 completely protected all 12 macaques studied. Further, partial depletion of NK cells, key mediators of Fc-dependent functions, did not abrogate the protective efficacy of PGT121 in 6 macaques. Additionally, in animals with established SHIVSF162P3 infection, SHIV viremia levels were equally rapidly reduced by LALA and WT PGT121. Our studies suggest that the potent neutralizing capacity of PGT121 renders the Fc-dependent functions of the Ab at least partially redundant. These findings have implications for Ab-mediated protection from and control of HIV-1 infection.